U.S. Agency Devotes $50 Million More to Fight Infectious Diseases Overseas

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

U.S. Agency Devotes $50 Million More to Fight Infectious Diseases Overseas

Washington Post (12/18/97) P. A15
Brown, David

Abstract: The U.S. Agency for International Development (AID) has allocated an additional $50 million this year for the control of infectious diseases found overseas--an investment AID administrator J. Brian Atwood called "a defense fund for the United States ...[and] for the entire world." The money will be divided among four areas that either affect, or have the potential to affect, the United States directly: control of tuberculosis, control of malaria, improved surveillance of disease outbreaks, and a broad effort to detect and limit drug -resistant microbes. The latter is an area of particular concern because it does not yet have a coordinated global program in place. The agency plans to use the money for programs intended to benefit the people and health care systems of the countries in which it is spent. AID currently spends an estimated $120 million annually on HIV and AIDS overseas, as well as $380 million on programs promoting the health of children. Over the next two months, AID will decide specifically how the money will be spent, although most of it will likely be used to enhance or expand existing programs run by the World Health Organization, the U.S. Centers for Disease Control and Prevention, and other organizations.

971218
AD972315

Copyright © 1997 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.